Iteos Therapeutics Is A Clinical Stage Biopharmaceutical Company Dedicated To Developing Innovative Immuno Oncology Therapies For Cancer Patientsfounded In April 2012The Company Operates From Dual Headquarters In Watertownmassachusettsand Gosseliesbelgiumiteos Specializes In Targeted Immunotherapies That Aim To Modulate The Tumor Microenvironmentaddressing Both Inflamed And Non Inflamed Tumors The Company S Pipeline Includes Several Promising Clinical Stage Programssuch As Belrestotugeos 448 An Anti Tigit Antibody In Late Stage Trialsand Eos 984A Small Molecule In Clinical Developmentadditionallythey Are Advancing Preclinical Programsincluding An Aa A Antagonist And A Sting Agonistfocusing On Enhancing Clinical Outcomes In Oncologyiteos Emphasizes A Scientific Approach That Combines Tumor Immunology And Translational Medicineaiming For First In Class Or Best In Class Therapies With A Commitment To Corporate Responsibilityiteos Integrates Esg Principles Into Its Operationsfocusing On Sustainable Value Creationthe Company Collaborates With Pharmaceutical Partners Like Pfizer To Advance Its Investigational Therapies Through Clinical Trialsprimarily Serving Oncology Patients
No conferences found for this company.
| Company Name | Iteos Therapeutics Sa |
| Country |
Belgium
|
| Address | N/A |
| Telephone | N/A |
| N/A |
